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Lippia origanoides is a honey shrub which has showed hypotensive potential assessed by in vivo studies. 
The aim of this work is the development of a pharmaceutical formulation composed by an optimized 
extract obtained from aerial parts of L. origanoides. The quantification of the naringenin marker in the 
dry extract and tablets developed was performed, as well as the assessment of the oral acute toxicity in 
rats. The hydroalcoholic extract of L. origanoides was spray-dried with the addition of colloidal silicon 
dioxide (Lo-HAE/CSD), and then applied in the preparation of eight different lots of tablets. The influence 
of the diluent (cellulose or babassu mesocarp), the presence of binder, and the percentage of lubricant, 
as well as organoleptic and physicochemical characteristics were screened. For the quantification of the 
marker content both in Lo-HAE/CSD and in the tablets, an analytical curve of the naringenin standard 
was fitted, and the samples were then analyzed in UFLC. The toxicological assessment was performed 
in female Wistar rats according to the Acute Toxic Class Method from OECD. The developed tablets 
produced meet acceptable macroscopic characteristics, and the presence of babassu as diluent provided 
improved physicochemical properties. The best content of Lo-HAE/CSD in the tablet (100.27%) was 
identified for the lot containing babassu, composed by 1.0% magnesium stearate, without PVP binder in 
its formulation. Moreover, Lo-HAE/CSD showed no signs of toxicity. Therefore, the babassu mesocarp 
powder is a promising pharmaceutical excipient for the development of herbal tablets containing the 
Lippia origanoides extract. 
Keywords: Lippia origanoides/pharmaceutical formulation/toxicity/. Babassu mesocarp. Factorial 
planning. Tablets.
INTRODUCTION
Lippia origanoides H.B.K. (Verbenaceae) is a 
honey plant native to Central America and northeastern 
South America, whose medicinal potential has been 
widely investigated due to the high amount of bioactive 
compounds identified, such as the flavanones naringenin 
and pinocembrin, and the flavones quercetin and luteolin 
(Stashenko et al., 2013; Barreto et al., 2014). Coelho et al. 
(2015) showed that a standardized hydroalcoholic extract 
of L. origanoides (Lo-HAE), obtained after optimization 
of extraction conditions, induces a significant hypotensive 
effect when administered intravenously or orally to rats, with 
duration of approximately 5 hours after oral administration. 
According to World Health Organization (2016), 
cardiovascular diseases are the main cause of death in 
the world, and hypertension is the main risk factor for 
the occurrence of these diseases. Taken together, the 
development of a pharmaceutical formulation from L. 
origanoides is markedly relevant, prospecting the industrial 
production of a new therapeutic herbal medicine for the 
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treatment of arterial hypertension. Among the already-
existing pharmaceutical forms, tablets are suitable choices 
for the long-term treatments, such as required for arterial 
hypertension. Tablets promote a systemic drug delivery 
through the convenient and safe administration of daily 
doses of the drug, then ensuring greater dose precision and 
having low cost and ease of production on an industrial scale 
(Guerra-Ponce et al., 2016; Klein et al., 2013).
However, focusing on the industrial-scale production 
of herbal medicines, the different drying techniques 
available are promising alternatives for the conservation 
and stocking of plant extracts, providing greater stability, 
preserving their physicochemical characteristics and 
pharmacological properties. Among these techniques, 
spray-drying is widely used in the herbal industry. Since 
the equipment allows the association with appropriate 
drying excipients (such as colloidal silicon dioxide), as 
well as the direct feed of liquids with direct discharge 
of powder, it is a productive and highly versatile 
method that confers stability and allows the control of 
the characteristics of the final product, thus ensuring 
reproducibility of the processes (Fernandes et al., 2014).
The babassu mesocarp (Orbygnia sp.), one of the 
main extractive products from Brazil, emerged as a raw 
material with great potential for the development of tablets 
in the pharmaceutical industry as an excipient, due to its 
composition of around 70% of starch. Starches are natural, 
profitable and non-toxic biopolymers, which is widely 
used as binders and disintegrants of the formulations 
(França et al., 2014). The advantages of using babassu 
mesocarp in pharmaceutical formulations versus the 
use of conventional excipients have been studied. A 
comparative statistical study can be performed, such as 
Factorial Planning, which compares the characteristics 
of formulations produced from different mixtures of 
excipients. Using this tool, simultaneous variables are 
analyzed with a reduced number of experiments, but not 
causing the lack of data quality (Lima et al., 2016). 
The use of plant extracts as bioactive raw materials 
requires the evaluation of their toxicity. In this sense, 
procedures which assess the toxicological profile of 
chemical products classify them according to their 
toxicological potentials, including lethality. Therefore, it 
is imperative that the toxicological assessment must be 
performed following internationally regulated protocols, 
such as the guidelines published by the Organization 
for Economic Cooperation and Development (OECD) 
(Jonsson et al., 2013). 
The present work aims to develop pharmaceutical 
tablet formulations and assess the acute oral toxicological 
profile for a spray-dried standardized extract of L. 
origanoides H.B.K., evaluating the influence of excipients 
in the process.
MATERIAL AND METHODS
Drugs and reagents
During the analyses, ethanol (purity >99.5%; Isofar, 
Petrópolis, RJ, Brazil) and ultra-purified water (Milli Q®, 
Merck Millipore, Darmstadt, Germany) were used. The 
standard naringenin (C15H12O15, 95.0%) was obtained from 
Sigma-Aldrich (St. Louis, MO, USA). For the analyses 
in UFLC, methanol (Labsynth, Diadema, SP, Brazil) 
and acetic acid (Vetec Química Fina, Rio de Janeiro, RJ, 
Brazil) both in HPLC grade were used.
The leaves of L. origanoides H.B.K. were collected 
in José de Freitas, Piauí, Brazil (latitude 04º45’23” south 
and longitude 42º34’32” west), in 2013. The determination 
of the species was realized at the Herbarium Graziela 
Barroso from Federal University of Piauí. The voucher 
specimen was deposited under nº TEPB 09205.
Preparation of the spray-dried L. origanoides 
hydroalcoholic extract (Lo-HAE) 
The hydroalcoholic extract of L. origanoides (Lo-
HAE) was obtained according to the procedure previously 
optimized and standardized by Coelho et al. (2015). 
For this purpose, the plant material was dried at room 
temperature and then milled with a knife mill. Then, 
1004 g of leaves were extracted by maceration with 8 L 
of ethanol / water (1: 1) for three days, filtering the extract 
and renewing the solvent every day. The hydroalcoholic 
extract (Lo-HAE) was subjected to rotation evaporation 
and after evaporation of ethanol, part of the material was 
subjected to drying for lyophilization in Micro Modulyo 
Edwards Lyophilizer coupled to a high vacuum ValPump 
VLP80 Savant pump and another part of the extract 
was intended for spray drying. In this step, Aerosil 200® 
(colloidal silicon dioxide) was added to the aqueous 
residue as a drying adjuvant at 30% of the mass of the 
solid residue of the Lo-HAE, previously determined 
according to the methodology described in the Brazilian 
Pharmacopoeia, 5th edition. The Lo-HAE plus colloidal 
silicon dioxide (Lo-HAE/CSD) was subjected to drying 
in Mini Spray Dryer (Büch; B-290), using inlet and outlet 
temperatures of 150 °C and 100 °C, respectively. The 
peristaltic pump speed (3 mL∙min-1) was maintained at 
10% of the maximum capacity of the equipment. The 
pressure was maintained constant (55 bar), and the air 
suction was adjusted at 80% of the total capacity.
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Preparation of the tablets by Factorial Planning 23
Using the spray-dried extract (Lo-HAE/CSD), 
powder mixtures were prepared for 8 (eight) different lots 
of tablets determined by factorial design (23), in which 
the following parameters were combined at two levels: 
diluent (microcrystalline cellulose (CMC) or babassu 
mesocarp powder), percentage of lubricant (magnesium 
stearate 1.0 or 0.5%), and presence or absence of the 
binder 1.0% polyvinylpyrrolidone (PVP), as shown in 
Table I. Microcrystalline cellulose PH 101 (supplier: 
Genix®, Brazil; Lot number: 90652) and magnesium 
stearate (supplier: Natural Pharma®, Brazil) were used. 
The babassu mesocarp powder was obtained from Ativa 
Vida Ltda, Brazil (Lot number: 1841003), and submitted 
to a bleaching process, in order to avoid interference 
of chromophore groups present in the further applied 
spectrophotometric analysis (Rosa et al., 2011). The 
bleaching process was performed using the methodology 
of Pereira (2010), with modifications.
Table II shows the composition followed for the 
development of each lot of tablets. All lots were produced 
by wet method, after previous granulation process in Mesh 
no. 2, using water-alcohol (1:1) to produce the granules 
and the dry extract in a spray-dryer at a dose of 50 mg. For 
the groups containing PVP, 1.0% polyvinylpyrrolidone 
solubilized in water-alcohol (1:1) was used in the 
granulation step. The compression was carried out in a 
single-punch tablet press (Monopress LM1, Lemaq, SP, 
Brazil) using a 5-mm punch.
Each lot (n=40) was assessed for macroscopic 
characteristics, including color, surface roughness, and 
the presence of physical defects, as well as the average 
weight (analytical balance, Sartorius model BL 210S), 
thickness and diameter (caliper, Starret® model 125/6), 
hardness (digital durometer, Nova Ética® model 298-
DGP), friability (friabilometer, Nova Ética® model 300), 
and disintegration time (disintegrator, Nova Ética® model 
301 AC), according the methodologies described in the 
Brazilian Pharmacopoeia V (2010).
Quantification of the marker Naringenin in dried 
extracts and tablets by UFLC
As previously reported by Coelho et al. (2015), 
quantitative analyses of Lo-HAE in the formulations 
can be performed based on the presence of the marker 
naringenin. For the quantification of the naringenin 
content in the spray-dried Lo-HAE/CSD, the sample was 
initially submitted to a clean-up in C18ec solid-phase 
extraction cartridge (Chromabond®) using methanol as 
the eluent, followed by filtration of the eluate on nylon 
filter (0.2 μm, Titan3). After drying, the methanolic 
solutions were prepared in triplicate at a concentration 
of 0.0495 mg∙mL-1 for injection in Ultra-Fast Liquid 
Chromatograph (UFLC) (Shimadzu Prominence), 
equipped with a DGU-20A3 degasser and pump Binary 
LC-20AD Shimadzu, coupled to a PDA UV detector 
(Shimadzu). The analysis conditions followed the 
methodology developed by Coelho et al. (2015), and 
the area of the signal relative to naringenin in Lo-HAE/
CSD was calculated. Using the linear equation obtained 
from the analytical curve fitted for the naringenin from 
six different concentrations (1.56, 2.08, 3.12, 3.64, 4.16 
and 4.68 mg∙L-1), the quantification of the marker content 
in the solutions were analyzed and quantified.
Regarding the quantification of naringenin in the 
tablets, only lots no. 2, 4, 6 and 8 which contained the 
TABLE I - Factorial planning matrix 23 for optimization of Lippia origanoides H. B. K. tablets. Diluent (cellulose-; babassu+); Use 
of PVP 1% as a binder (no -, yes +), Lubricant (0,5% -; 1,0% +). Interaction of parameters 1 e 2 (1/2); Interaction of parameters 1 
e 3(1/3); Interaction of parameters 2 e 3 (2/3); e Interaction of parameters 1, 2 e 3 (1/2/3)
Assay Diluent (1) Presence of Binder (2) Lubricant (3) (1/2) (1/3) (2/3) (1/2/3)
1 - - - + + + -
2 + - - - - + +
3 - + - - + - +
4 + + - + - - -
5 - - + + - - +
6 + - + - + - -
7 - + + - - + -
8 + + + + + + +
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babassu mesocarp powder as diluent were analyzed, since 
they meet the best quality parameters. For this purpose, 
tablet samples from each lot were analyzed by UFLC, in 
triplicate, under the same conditions as described above.
In vitro dissolution assay
The dissolution test was carried out only for lots 
containing babassu mesocarp powder as diluent, due 
to the lots containing cellulose did not meet the quality 
criteria in the disintegration test. A calibration curve for 
the hydroalcoholic extract of L. origanoides was fitted at 
concentrations of 10.4; 15.2; 24; 32 and 40 μg∙mL-1 in 0.1 
M HCl, and read at the wavelength of 290 nm, according 
to previous scanning. Then, the naringenin content in 
tablets dissolved using a dissolution test equipment (Nova 
Ética®, model 299, Brazil) were calculated. The parameters 
of rotation were defined as follow: speed at 50 RPM; 
temperature at 37 °C; and 900 mL of 0.1 M HCl medium per 
vessel. The samples were collected at 5, 10, 15, 30, 45, 60 
and 75 minutes, according to the Brazilian Pharmacopoeia 
5th ed (2010) guideline for dissolution of immediate release 
tablets. The dissolution curves were plotted using GraphPad 
Prism version 6.00 for Windows, (GraphPad Software, La 
Jolla California USA, www.graphpad.com).
In vivo toxicological assessment of spray-dried 
Lo-HAE
Animals
Female Wistar rats (230 ± 30 g; 4 months-old) were 
kept in cages and separated by experimental group. The 
room temperature was maintained at 24 ± 2 °C, under 
light-dark cycle of 12/12 hours. The rats were fasted for 
12 h prior to administration, with the food reintroduced 
3 h after administration. Thereafter, water and food were 
administered ad libitum. This study was approved by the 
Animal Experimentation Ethics Committee of the Federal 
University of Piauí (nº 008/12). All animals were treated in 
accordance with the principles defined by the Resolution 
No. 1000/2012 of the Federal Council of Veterinary 
Medicine, Brazil.
Acute oral toxicity test
The toxicological assessment was carried out 
in accordance with the Guideline no. 423 from the 
Organization for Economic Cooperation and Development 
(OECD) and the Acute Toxicity Class Method. Briefly, 
rats were initially divided into two groups of three animals 
each; group 1 were orally treated with Lo-HAE/CSD at the 
single dose of 2000 mg/kg (equivalent to 1400 mg/kg of 
Lo-HAE and 600 mg/kg of colloidal silicon dioxide), and 
group 2 were orally treated with distilled water (vehicle). 
Thereafter, the hippocratic screening was carried out, 
where animals were individually observed for clinical and 
behavioral alterations. After 14 days of daily observation, 
the animals were euthanized, and gross pathological 
(macroscopic) analyses of the heart, liver, lung, spleen 
and kidneys were performed.
Statistical analysis
The results were analyzed, and significances were 
determinated by analysis of variance (ANOVA). The 
statistical analyses and curve fitting were performed using 
GraphPad Prism version 6.00 for Windows, (GraphPad 
Software, La Jolla California USA, www.graphpad.com). 
Pareto and surface charts were constructed, respectively, 
using the software Excel® version 2013 (Microsoft, www.
microsoft.com) and Statistica® version 12 (StatSoft, www.
statsoft.com.br).
RESULTS AND DISCUSSION
Spray-dryed Lo-HAE and characteristics of tablets 
produced by Factorial Planning 23
The drying of Lo-HAE in a spray-dryer showed a 
yield of 77.94%. This yield is satisfactory and exceeds the 
yields normally obtained in laboratory-scale spray-drying, 
TABLE II - Definition of the composition of the different lots of tablets according to the factors under study (diluent, presence of 
binder and percentage of lubricant)
Lot Number Diluent Presence of PVP Binder
Lubricant 
(%) Number of lot Diluent
Presence of 
PVP Binder
Lubricant 
(%)
Lot 1 Cellulose No 0.5 Lot 5 Cellulose No 1.0 
Lot 2 Babassu No 0.5 Lot 6 Babassu No 1.0 
Lot 3 Cellulose Yes 0.5 Lot 7 Cellulose Yes 1.0 
Lot 4 Babassu Yes 0.5 Lot 8 Babassu Yes 1.0 
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which are around 50 to 70% (Li et al., 2010). Therefore, 
the spray-drying technique demonstrates efficiency in 
providing the optimized extract of L. origanoides for the 
production of tablets.
In the macroscopic analysis of the tablets, all the 
lots presented adequate characteristics, such as circular, 
flat, free of cracks or deformations (Table III). Besides, 
the average weight (100 mg) demonstrated satisfactory 
results according to the Brazilian Pharmacopoeia 5th ed. 
(2010). For uncoated tablets weighting between 80 mg 250 
mg, the allowed variation limits must be around ±7.5%. 
The uniformity of the characteristics of the tablets was 
maintained when the diameters were analyzed. They all 
had 5 mm, which demonstrates the quality of the punches, 
although a significant difference was observed between the 
thickness of lots containing babassu tablets (lots 2, 4 and 
6) and two lots containing cellulose and 1.0% magnesium 
stearate (Lots 5 and 7).
Two main ways to evaluate the resistance of 
tablets are the analysis of friability and hardness. Tablets 
are expected to present some resistance to impacts of 
the productive process, transportation and storage. 
Furthermore, physical resistance is a key feature in 
the development of tablets since administration of the 
therapeutic dose might be impaired due to the loss 
of powder and fragments that further compromise 
the performance of the pharmaceutical form in both 
disintegration steps and in vivo dissolution of the drug 
(Nart et al., 2017).
According to Table III, the friability analysis 
shows that all lots meet the requirement of the Brazilian 
Pharmacopoeia 5th ed. (2010), where the tolerable friability 
limit is 1.5% of weight. For the hardness, which represents 
the resistance of the tablet to crushing or rupture under 
radial pressure, lots have also proved to be satisfactory. 
However, the hardness of the lots produced with babassu 
mesocarp is significantly lower when compared to lots 
produced with cellulose. For the study of the influence 
exerted by each factor on hardness, as well as their 
interactions, the limit value for significance was calculated 
with 95% of confidence (Anova followed by Tukey’s post 
test), and only values above 1.37 N may be considered 
significant for the response obtained. Thus, the Pareto 
Graph was plotted (Figure 1), where it is possible to note 
that the diluent (babassu or cellulose) promoted the most 
influenced the increase in hardness, providing a gain of 
63 N when the formulation contains cellulose (encoded 
as negative value in the Factorial Planning 23 matrix). In 
addition, the presence of the PVP binder also significantly 
influenced the hardness of the tablets, increasing this 
parameter by 21 N. The lubricating factor did not present 
significant influence. Regarding the interaction between 
the factors, it can be observed that the diluent and binder 
increase the hardness when this interaction is negative, 
which can be represented, according to the factorial design 
matrix 23, by the occurrence of cellulose as a diluent and 
the presence of PVP. Similarly, the three factors associated, 
when a negative interaction is generated, can increase the 
hardness by 15.25 N. It can be assumed that the presence 
of cellulose as a diluent is the main factor which is related 
to the well-known dry binder effect of this excipient (Nart 
et al., 2017).
Similar to the Pareto Graph, the surface charts of 
factorial design 23 (Figure 2) shows the evolution of tablets 
hardness when the diluent is changed from babassu (+) to 
cellulose (-) (Figure 2a), and in the presence (+) or absence 
(-) of the PVP binder (Figure 2b), or the magnesium stearate 
lubricant (Figure 2c). The significantly higher hardness of 
TABLE III - Result of quality control analyzes for developed tablets. ANOVA followed by Tukey post-test: a: significantly higher 
in relation to the groups whose babassu comprised the formulation (p<0.01); b: significantly less than lots 5 and 7, (p<0.05). D.T: 
Disintegration time; Content: content of marker naringenin
Lot number Average weight (g)
Thickness 
(mm)
Diameter 
(mm) Friability (%) Hardness (N) D.T (min) Content (%)
 1 100.7±1.59 4.9±0.06 5 0.44 95.88±1.75 a 49
2 99.97±1.4 4.8±0.00 b 5 0.8 35.13±1.50 25 92.76
3 100.58±1.25 4.9±0.00 5 0.52 99±0.71 a 48
4 100.43±1.05 4.8±0.00 b 5 0.16 36.75±2.60 27 84.72
5 101.82±1.41 5±0.1 5 0.53 61.5±1.47 a 44
6 100.05±1.14 4.8±0.00 b 5 0.29 30.63±2.02 17 100.27
7 101.66±0.88 5±0.00 5 0.64 124.25±1.76 a 47
8 100.92±1.42 4.9±0.12 5 0.38 39.37±1.6 17 90.08
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the cellulose containing tablets directly influences upon 
the disintegration time. However, although the direct ratio 
of hardness to tablet disintegration time is consistent with 
its mechanical resistance standard, it cannot be established 
as a rule, since the mechanical resistance of tablets is also 
determined by the compression technique employed, the 
density and the flow properties of the powders (active and 
excipients) (Ferreira et al., 2013).
FIGURE 1 - Pareto Graph for factorial planning 23 results, considering the effects produced in the hardness. Dashed line defines 
95% confidence interval. Interaction of parameters 1 and 2 (1/2); Interaction of parameters 1 and 3(1/3); Interaction of parameters 
2 and 3 (2/3); and Interaction of parameters 1, 2 and 3 (1/2/3).
FIGURE 2 - Surface graphics of factorial planning 23 for effects produced in hardness (N), from the factors: diluent (cellulose -, 
babassu +); Use of PVP as a binder (no -, yes +), lubricant (0.5% -; 1.0% +).
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As followed for the hardness test, the significance 
was considered with 95% of confidence for the 
disintegration time, and only values  above 2.49 min could 
be considered as significant. According with Pareto Graph 
(Figure 3), it can be seen that the diluent factor was the 
one that most influenced the increase in the disintegration 
time, yielding a gain of 25.33 min when the formulation 
contains cellulose. On the other hand, the presence of 
the PVP binder did not significantly have any influence, 
whereas the lubricant in the 0.5% concentration increased 
in 5.83 min the disintegration time. Considering the 
interaction between the factors, it can be seen that only the 
association between diluent and lubricant (which increases 
the disintegration time when this interaction is negative) 
can be represented, according to the factorial planning 
matrix 23, by the occurrence of cellulose as diluent and 
the presence of 1.0% magnesium stearate, or even by the 
occurrence of babassu as a diluent and 0.5% lubricant.
According to the surface chart of effects produced 
at the disintegration time, the direct relationship with the 
hardness of the tablets is related to the type of diluent 
used can be noted, with longer disintegration times when 
the diluent cellulose (-) was used instead of babassu (+) 
(Figure 4a). Besides, longer disintegration times (>35 
min) have been related to the presence of lubricant at 
the concentration of 0.5% (-), when compared with the 
concentration of 1.0% (+), where times less than 31 min 
was obtained (Figure 4c). However, this result contrasts 
with the expected, since the higher concentration of 
the lubricant could be related to a longer disintegration 
time of the formulation. Considering the hydrophobic 
nature of magnesium stearate, there is a predisposition 
to cover particles, and making difficult penetration of 
water into the tablet, and then could promote a delay in 
the disintegration time (Li, Wu, 2014; Soares, Petrovick, 
1999). On the other hand, the effect of lubricants on 
the tablets depends not only on their physicochemical 
nature, but also on the presence of active substances 
and other excipients which may influence the role of 
the lubricant in increase the disintegration time of the 
formulation, such as the disintegrating agents (Wang, Wen, 
Desai, 2010). In the study by Bolhuis et al. (1982), the 
presence in tablets of the disintegrant 4.0% sodium starch 
glycolate renders the disintegration time independent of 
the presence of magnesium stearate. In these sense, the 
lower disintegration times observed for the presence of 
the 1.0% magnesium stearate may be possibly related 
to the presence of babassu mesocarp powder might. 
In accordance with stated above, its potential use in 
tablet development as a function of the demonstrated 
disintegrating ability is closely related to the high starch 
content of this extractive product.
Besides, it was also suggested that the disintegration 
time is increased at the 0.5% concentration of lubricant due 
to the influence of the PVP binder. PVP has the potential 
to make the granules more cohesive, and then impairing 
the disintegration of the formulations (Figure 4c) (Late, 
Yu, Banga, 2009). However, as shown in the Pareto graph 
(Figure 3), the presence of binder in the formulation did 
not result in a statistically significant influence.
FIGURE 3 - Pareto Graph for factorial planning 23 results, considering the effects produced in the disintegration time. Dashed line 
defines 95% confidence interval. Interaction of parameters 1 and 2 (1/2); Interaction of parameters 1 and 3(1/3); Interaction of 
parameters 2 and 3 (2/3); and Interaction of parameters 1, 2 and 3 (1/2/3).
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Thus, according the criteria established in the 
Brazilian Pharmacopoeia 5th ed. (2010), the maximum 
disintegration time accepted for immediate-release tablets 
is 30 minutes. Therefore, only the tablets containing 
babassu meet a satisfactory disintegration time of less than 
30 minutes, whereas the tablets containing cellulose as 
diluent were not approved in this test (Table III; Figure 3).
Determination of the naringenin marker on Lo-
HAE/CSD and tablets
For the quantification of naringenin in the spray-
dried extract, the signal area relative to the marker present 
in the chromatogram was analyzed. The data of signal 
area were plotted on the line equation (y = 42313.5809x - 
11226.3496) previously obtained from the analytical curve 
of the marker naringenin (R = 0.9993). The concentration 
of naringenin detected in the spray-dried extract was 3.73 
g%. Such result is satisfactory, since the same content of 
the marker was detected in the lyophilized extract of L. 
origanoides (37.3 mg of Naringenin per gram of Lo-HAE, 
or 3.73 g%), as presented by Coelho et al. (2015). Thus, 
the application of spray-drying technique as well as the 
presence of Aerosil® as a drying adjuvant did not influence 
the naringenin content in the Lo-HAE, making safe the 
use of this technique for the production of dry extracts 
for pharmaceutical application as raw materials in the 
industrial production of tablets.
Furthermore, the quantification of naringenin 
content in the tablets using the linear equation obtained 
for this marker was also performed, as well as the Lo-HAE 
content present in the formulations (Table III). The results 
showed that formulation 6 (Babassu as diluent, without 
PVP and 1.0% of lubricant) provided the best result, 
since it presented a naringenin content of 100.27%, thus 
ensuring the Lo-HAE content of 50 mg in this lot, which 
is required in the preparation of the formulations. Thus, 
the formulation present in lot 6 is more suitable according 
the proposed analytical method.
Dissolution test
The tablet dissolution step is markedly decisive 
for delivery of drugs towards the site of action. After 
dissolution, the drug is released from this pharmaceutical 
form, and becomes available to be absorbed. Many factors 
can interfere in the process of tablet dissolution, such as the 
particle size, solubility, and chemical nature of the drug, 
as well as the composition in excipients of the formulation 
(Arrunátegui et al., 2015; Cristofoletti, Dressman, 2017).
FIGURE 4 - Surface graphics of factorial planning 23 for effects produced in disintegration time (min), from the factors: diluent 
(cellulose -, babassu +); use of PVP as a binder (no -, yes +), lubricant (0.5% -; 1.0% +).
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The FDA (Food and Drug Administration, USA) 
states that these formulations must release 85% of the 
active substance between the initial 15 and 60 minutes of 
the test, according to the biopharmaceutical characteristics 
of the drug (FDA-CDER, 1997). In this work, only lots 
containing PVP meet this specification, since almost all 
Lo-HAE present in the tablets were released within 60 
minutes of assay. Furthermore, the better dissolution 
profiles were obtained for the lots containing magnesium 
stearate at the lowest concentration (0.5%) (Figure 5). 
This fact is justified by the characteristic insolubility of 
the lubricants which delay the dissolution process. On 
the other hand, the starch as the major constituent of 
the babassu mesocarp powder facilitates the dissolution 
process, since this excipient also acts as a disintegrant in 
the formulations. In addition, spray-drying process is able 
to reduce the size of the dried extract particles, and thus 
improve their dissolution. Finally, the dissolution profile 
obtained for the tablets can also be related to the wet 
granulation process performed, which generally confers 
more hydrophilic characteristics to the poorly soluble 
constituents (Li, Wu, 2014).
As mentioned above, it is widely accepted that 
the use of babassu mesocarp powder is able to improve 
the production of tablets due to its physicochemical 
characteristics favorable to the release of active 
compounds. These characteristics can be valuable in order 
to allow the bioactive compounds present in the optimized 
extract of L. origanoides to be released in order to exert 
the hypotensive activity previously reported by Coelho 
et al. (2015). In addition, the quantification of marker 
compounds in developed formulations represents a marked 
aspect in the production of herbal medicines in industrial 
scale. The control quality is performed as the content of 
plant active compounds, which ensures the reproducibility 
of the production process, as well as the efficacy and safety 
of the herbal medicine for potential consumers.
Acute toxicity test of Lo-HAE/CSD
According to OECD Guideline no. 423, a sample 
is considered to be practically non-toxic when it presents 
a value LD50 above 2,000 mg/kg or between 2,000 
and 5,000 mg/kg (OECD, 2002). The colloidal silicon 
dioxide is widely used in oral and topical pharmaceutical 
formulations, being considered as an essentially non-toxic 
and non-irritating excipient, since only intraperitoneal 
and subcutaneous administration can produce reactions 
to local tissues and/or granulomas. The LD50 values in 
rats for this excipient are 0.015 g/kg by intravenous route 
(IV), and 3.16 g/kg for oral route (VO) (Rowe, Sheskey, 
Quinn, 2009). In the present study, no death was observed 
during the study period after single oral administration of 
Lo-HAE/CSD at the dose of 2,000 mg/kg. Thus, it can be 
inferred that the presence of colloidal silicon dioxide as 
a drying adjuvant at the equivalent dose of 600 mg/kg in 
Lo-HAE/CSD did not cause any death. Thus, Lo-HAE/
CSD can be classified in category X of GHS (Globally 
Harmonized System), which refers to substances where 
neither death nor toxicological effects were observed.
According to Cunha et al. (2009), the hippocratic 
screening is a useful trial in the preliminary screening of 
plants for the detection of possible pharmacological and 
toxicological activities. It provides a general estimate 
of the toxicity of a substance, regarding the activity and 
coordination of the motor system, as well as the reflexes 
and activities on the central and autonomic nervous system 
of the tested species. Regarding the hippocratic screening 
performed, after the administration of Lo-HAE/CSD at the 
single dose of 2,000 mg/kg, no alterations in clinical or 
behavior parameters of the treated group was observed. 
The same result of hippocratic screening was reported by 
Coelho et al. (2015), after administration of Lo-HAE at 
dose of 2,000 mg/kg. In addition, in the acute toxicity test 
conducted by Coelho et al. (2015), no weight loss was 
observed after administration of the 2,000 mg/kg dose of 
Lo-HAE, reinforcing the safe use of this extract. Thus, the 
Lo-HAE and colloidal silicon dioxide in Lo-HAE/CSD at 
equivalent doses of 1,400 and 600 mg/kg, respectively, did 
not affect the analyzed toxicological parameters
After euthanasia of the animals, the organs of the 
abdominal and thoracic cavities (liver, kidneys, heart, 
FIGURE 5 - Dissolution profile of lots containing babassu as 
diluent (B). B + 0.5 MS: Magnesium Stearate 0.5%; B + 0.5 MS 
+ PVP: Magnesium Stearate 0.5% and PVP as a binder; B + 1.0 
MS: Magnesium Stearate 1%; B + 1.0 MS + PVP: Magnesium 
stearate 1.0% and PVP as a binder.
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spleen and lungs) were macroscopically evaluated. 
No changes were detected in the size, stiffness, 
structure or coloring of the surfaces, when compared 
to the control group. The OECD and the Society of 
Toxicological Pathology (STP) considers as non 
recommended the analysis of both relative organ weights 
and histopathological studies in acute toxicity tests, 
since a single exposure to the test substance may not be 
conclusive about toxicological assessment. According 
to the STP, the determination of relative organ weights 
and histopathological analysis should be performed after 
treatment for at least 7 days, unless visible macroscopic 
changes could be observed (OECD, 2002; Sellers, 2007).
CONCLUSION
The tablets containing the babassu mesocarp 
powder demonstrated more significant physicochemical 
characteristics when compared to the tablets containing 
cellulose as diluent. It is possible to associate the presence 
of this excipient with the improvement of hardness and 
disintegration time of tablets. Therefore, the use of babassu 
mesocarp powder in the development of a pharmaceutical 
formulation based on L. origanoides is advantageous. 
Besides, the determination of naringenin content in 
the developed formulations was also possible, which 
represents an imperative criterion for the development of 
pharmaceutical formulations containing plant extracts. In 
addition, according to the acute oral toxicity test by Acute 
Toxic Class Method (OECD), Lo-HAE/CSD showed no 
signs of toxicity, reinforcing future expectations for the 
development of herbal formulations.
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